|
PSMD12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.836300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.702400E-01 |
| Normal-vs-Stage2 |
3.226800E-01 |
| Normal-vs-Stage3 |
7.299700E-02 |
| Normal-vs-Stage4 |
1.362360E-01 |
| Stage1-vs-Stage2 |
6.378200E-01 |
| Stage1-vs-Stage3 |
2.025000E-01 |
| Stage1-vs-Stage4 |
2.076200E-01 |
| Stage2-vs-Stage3 |
6.081400E-01 |
| Stage2-vs-Stage4 |
2.593200E-01 |
| Stage3-vs-Stage4 |
4.010800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.410500E-02 |
| Normal-vs-AfricanAmerican |
4.015800E-01 |
| Normal-vs-Asian |
4.121200E-01 |
| Caucasian-vs-AfricanAmerican |
4.587000E-01 |
| Caucasian-vs-Asian |
5.845600E-01 |
| AfricanAmerican-vs-Asian |
4.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.811200E-01 |
| Normal-vs-Female |
8.2925000000067E-05 |
| Male-vs-Female |
3.032600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.030200E-01 |
| Normal-vs-Extreme_Weight |
4.187000E-01 |
| Normal-vs-Obese |
1.857220E-01 |
| Normal-vs-Extreme_Obese |
4.344000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.221400E-01 |
| Normal_Weight-vs-Obese |
9.554600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.949800E-01 |
| Extreme_Weight-vs-Obese |
5.988000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.316800E-01 |
| Obese-vs-Extreme_Obese |
7.206800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.223700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.721730E-03 |
| Normal-vs-Age(61-80Yrs) |
7.598400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.760400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.348560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.776100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.199510E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.662100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.708000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.161800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.492600E-01 |
| Normal-VS-Type2 PRCC |
1.613390E-01 |
| Normal-VS-KIRP CIMP |
6.478300E-03 |
| Normal-VS-Unclassified PRCC |
1.415650E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.831200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.521300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.308600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.902200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.358400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.148500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.266800E-01 |
| Normal-vs-N1 |
8.804200E-03 |
| Normal-vs-N2 |
4.065800E-01 |
| N0-vs-N1 |
1.284340E-02 |
| N0-vs-N2 |
2.156000E-01 |
| N1-vs-N2 |
7.624800E-01 |
|
|
